Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Matinas BioPharma Holdings Inc. (MTNB)

1.19   -0.06 (-4.8%) 02-21 16:00
Open: 1.23 Pre. Close: 1.25
High: 1.26 Low: 1.18
Volume: 2,491,683 Market Cap: 232M
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.262 - 1.271 1.271 - 1.277
Low: 1.158 - 1.169 1.169 - 1.178
Close: 1.174 - 1.19 1.19 - 1.202

Technical analysis

as of: 2020-02-21 4:32:13 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.73     One year: 1.95
Support: Support1: 1.17    Support2: 0.97
Resistance: Resistance1: 1.48    Resistance2: 1.67
Pivot: 1.31
Moving Average: MA(5): 1.27     MA(20): 1.35
MA(100): 1.27     MA(250): 1.05
MACD: MACD(12,26): -0.09     Signal(9): -0.08
Stochastic oscillator: %K(14,3): 23.33     %D(3): 29.68
RSI: RSI(14): 35.75
52-week: High: 2.49  Low: 0.58  Change(%): 9.2
Average Vol(K): 3-Month: 328424  10-Days: 189125

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
MTNB has closed above bottom band by 4.6%. Bollinger Bands are 48.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to MTNB's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 12 Feb 2020 15:08:40 +0000
Analysts: These 3 Penny Stocks Are Positioned for Big Gains in 2020

Fri, 31 Jan 2020 16:14:18 +0000
5 Stocks Under $5 With Colossal Growth Prospects

Wed, 29 Jan 2020 16:41:15 +0000
Acasti Pharma Stock Has One Last Chance

Tue, 07 Jan 2020 21:02:00 +0000
Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today

Thu, 26 Dec 2019 16:23:20 +0000
5 Strong Buy Stocks Under $5 With Massive Upside Potential

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 162.74
Shares Float (M) 141.86
% Held by Insiders 8.46
% Held by Institutions 18.30
Shares Short (K) 6810
Shares Short P. Month (K)

Stock Financials

EPS -0.124
Book Value (p.s.) 0.210
PEG Ratio
Profit Margin
Operating Margin -19320.00
Return on Assets (ttm) -36.6
Return on Equity (ttm) -63.9
Qtrly Rev. Growth
Gross Profit (p.s.) -0.041
Sales Per Share
EBITDA (p.s.) -0.105
Qtrly Earnings Growth
Operating Cash Flow (M) -11.81
Levered Free Cash Flow (M) -8.07

Stock Valuations

P/E -9.60
P/E Growth Ratio -0.05
P/BV 5.67
P/CF -16.40

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.